XML 30 R19.htm IDEA: XBRL DOCUMENT v3.24.4
Note 14 – Common Stock
 6 Months Ended
Oct. 31, 2024
Equity [Abstract]  
Note 14 – Common Stock

Note 14 – Common Stock

 

Our common stock has a par value of $0.001 per share. We are authorized to issue 500,000,000 shares of common stock. Each share of common stock is entitled to one vote. A summary of shares of common stock issued by the Company since April 30, 2023 is as follows:

 

Description of Shares  Shares Issued
Shares outstanding as of April 30, 2023   54,568,065 
Vesting of restricted stock to employees, net of shares withheld of 27,189 to pay taxes   192,742 
Vesting of restricted stock to Board of Directors   252,214 
Vesting of restricted stock to consultants   1,761 
Conversion of preferred stock   818,334 
Issuance of common stock through ATM facilities   53,235 
Issuance of common stock through public offering   18,400,000 
Exercise of stock options   3,000 
Shares outstanding as of April 30, 2024   74,289,351 
Vesting of restricted stock to employees, net of shares withheld of 138,744 to pay taxes   540,590 
Vesting of restricted stock to Board of Directors   61,447 
Exercise of stock options   58,446 
Exercise of warrants   530,578 
FlightWave acquisition   2,544,991 
Shares outstanding as of October 31, 2024   78,025,403 

    

See note 20 for subsequent events. 

 

Public Offering

 

In December 2023, the Company entered into an underwriting agreement with ThinkEquity LLC, as representative of the underwriters, pursuant to which the Company agreed to sell to the underwriters in a firm commitment underwritten public offering (the “Offering”) an aggregate of 16,000,000 shares of the Company’s common stock, par value $0.001 per share, at a public offering price of $0.50 per share. The Company also granted the underwriters a 45-day option to purchase up to an additional 2,400,000 shares of Common Stock to cover over-allotments. 

  

The Offering closed on December 11, 2023, resulting in the issuance of 18,400,000 shares of Common Stock which generated gross proceeds of $9,200,000. Net proceeds to the Company from the Offering, after deducting the underwriting discount, the underwriters’ fees and expenses and the Company’s estimated Offering expenses, were approximately $8,400,000.